Hanmi Pharmaceutical Co., Ltd.

South Korea-based pharmaceutical company offering comprehensive CDMO services including peptide manufacturing. Operates state-of-the-art cGMP approved facilities. Provides end-to-end services throughout the entire pharmaceutical life cycle, from raw material supply (chemical API, peptide, PEG, mRNA cap analog, NTP, lipid) through to finished dosage form manufacturing. Affiliate Hanmi Fine Chemical specializes in high-tech CDMO services for small molecule APIs and peptide production.

Hanmi Pharmaceutical Co., Ltd. is listed as a cdmo in the peptide supply chain, serving Asia markets from South Korea. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 2 independent sources, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.